PAR Capital Management’s Elevance Health ELV Stock Holding History

PAR Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20,000	Closed	-$4.8M	–	47
2019 Q3	$4.8M	Hold	20,000	–	–	0.08%	41
2019 Q2	$5.64M	Hold	20,000	–	–	0.09%	41
2019 Q1	$5.74M	Sell	20,000 -55,000	-73%	-$15.9M	0.11%	43
2018 Q4	$19.7M	Buy	75,000 +5,000	+7%	+$1.37M	0.33%	34
2018 Q3	$19.2M	Buy	+70,000	New	+$18.2M	0.22%	53
2014 Q2	–	Sell	-100,000	Closed	-$9.96M	–	66
2014 Q1	$9.96M	Sell	100,000 -2,100	-2%	-$190K	0.3%	44
2013 Q4	$9.43M	Sell	102,100 -650,000	-86%	-$57.8M	0.31%	42
2013 Q3	$62.9M	Sell	752,100 -1,747,900	-70%	-$150M	1.93%	16
2013 Q2	$205M	Buy	+2,500,000	New	+$187M	5.75%	5

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

PAR Capital Management's ELV Position: Q4 2019 in Review

PAR Capital Management sold out of Elevance Health (ELV) in Q4 2019, closing a stake of 20,000 shares — an estimated $4.8M sold.

PAR Capital Management first reported a position in ELV in Q2 2013 and held it in 9 quarters. The position peaked at $205M in Q2 2013. 1,110 funds tracked by Wall St. Rank hold ELV as of Q4 2019.

PAR Capital Management reported no remaining Elevance Health position as of Q4 2019 after selling out during the quarter.
PAR Capital Management sold 20,000 Elevance Health shares in Q4 2019, an estimated $4.8M.
PAR Capital Management first reported a position in Elevance Health in Q2 2013 and held it in 9 quarters.
PAR Capital Management's Elevance Health position peaked at $205M in Q2 2013.
1,110 funds tracked by Wall St. Rank held Elevance Health as of Q4 2019.

Based on PAR Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.